Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Grant/Award of 120,000 TNYA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 120,000 | n/a |
| Jan 16, 2026 | Eledon Pharmaceuticals, Inc. (ELDN) | Exercise/Conversion | 3,430 | n/a |
| May 30, 2025 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 107,400 | n/a |
| Jan 13, 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 30,870 | n/a |
| Oct 22, 2024 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 34,000 | n/a |
| Jun 13, 2023 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 29,532 | n/a |
| May 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 150,437 | n/a |
| Feb 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 20,000 | n/a |
| Jun 14, 2022 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 39,727 | n/a |
| Feb 2, 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 20,000 | n/a |